A provider briefing on the Cleocin (Clindamycin) shortage in 2026. Current status, prescribing implications, alternatives, and tools for patient access.
Clindamycin remains one of the most prescribed antibiotics in the United States — and one of the most affected by chronic drug shortages. As a prescriber, understanding the current supply landscape is essential for managing patient expectations, selecting alternatives when needed, and ensuring continuity of care.
This briefing covers the current status of the Cleocin (Clindamycin) shortage, its prescribing implications, available alternatives, and tools to help your patients access their medications.
The Clindamycin shortage — particularly for injectable formulations — is one of the longest-running drug shortages in the U.S.:
The shortage has several direct implications for clinical practice:
The injectable shortage most directly affects hospital pharmacies, surgical centers, and infusion clinics. Institutions may face allocation limits from their group purchasing organizations (GPOs) and distributors. Pharmacy and therapeutics (P&T) committees should have contingency protocols in place, including:
For outpatient prescribing, oral Clindamycin capsules are generally available from multiple generic manufacturers (including Greenstone/Pfizer, Amneal, Alembic, and others). However, individual pharmacies may experience temporary stock-outs due to:
Consider writing prescriptions with "dispense as written" flexibility to allow pharmacists to fill with any available manufacturer.
Clindamycin is frequently the first-line alternative for penicillin-allergic patients, particularly for dental prophylaxis and skin/soft tissue infections. The shortage makes it especially important to:
| Formulation | Status | Notes |
|---|---|---|
| Injectable (Clindamycin phosphate) | Shortage | On ASHP list since 2015. Multiple manufacturers on back order. |
| Oral capsules (75 mg, 150 mg, 300 mg) | Generally available | Multiple generic manufacturers. Sporadic pharmacy-level stock-outs. |
| Oral solution (75 mg/5 mL) | Generally available | Useful alternative when capsules unavailable. |
| Topical gel/lotion/solution (1%) | Available | New generic approval from Glenmark adds supply. |
| Vaginal cream/suppositories | Available | Stable supply from multiple manufacturers. |
Cost can be a barrier to access for uninsured or underinsured patients:
For patients struggling with cost, direct them to our savings guide: How to Save Money on Cleocin. For a provider-focused cost resource, see how to help patients save money on Cleocin.
Medfinder offers real-time pharmacy inventory search that your staff can use to help patients locate Clindamycin in stock near them. Instead of asking patients to call pharmacy after pharmacy, you can search stock from your office and direct patients to specific pharmacies with confirmed availability.
When Clindamycin is unavailable, consider these alternatives based on clinical indication:
For patient-facing information on alternatives, direct patients to our Cleocin alternatives guide.
Monitor the ASHP Drug Shortage Resource Center for real-time updates on Clindamycin availability, manufacturer communications, and alternative therapy recommendations.
The Clindamycin injection shortage shows no signs of near-term resolution. The fundamental drivers — limited sterile manufacturing capacity, thin profit margins for generics, and supply chain consolidation — are structural issues that require systemic solutions.
Oral and topical forms are in better shape, with new generic entrants adding manufacturing capacity. The broadening of telehealth has also improved patient access to prescriptions, reducing barriers for patients in underserved areas.
As a provider, the most impactful steps you can take are:
The Clindamycin shortage is a complex, multi-year challenge that directly impacts patient care across nearly every specialty. By staying informed, maintaining flexible prescribing practices, and leveraging tools like Medfinder, providers can help ensure their patients continue to receive effective antibiotic therapy even when first-line options are constrained.
For additional provider resources, see our guide on helping patients find Cleocin in stock.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
